Eva M. Boorsma
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure.
Journal: Physiological reports
Published: January 15, 2025
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.
Journal: European journal of heart failure
Published: April 07, 2024
Characteristics and Clinical Outcomes of Patients Hospitalized for Acute Heart Failure Who Develop Atrial Fibrillation or Convert to Sinus Rhythm.
Journal: Journal of cardiac failure
Published: December 22, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome.
Journal: European journal of heart failure
Published: October 03, 2022
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial.
Journal: Journal of cardiac failure
Published: May 12, 2022
Albuminuria as a marker of systemic congestion in patients with heart failure.
Journal: European heart journal
Published: February 28, 2022
Renal Compression in Heart Failure: The Renal Tamponade Hypothesis.
Journal: JACC. Heart failure
Published: October 12, 2021
Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 16, 2021
Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure.
Journal: European journal of heart failure
Published: January 20, 2021
Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure.
Journal: European journal of heart failure
Published: January 11, 2021
Last Updated: 09/26/2026